| Literature DB >> 29983119 |
Louise A E Brown1, Sebastian C Onciul1, David A Broadbent1,2, Kerryanne Johnson1, Graham J Fent1, James R J Foley1, Pankaj Garg1, Pei G Chew1, Kristopher Knott3, Erica Dall'Armellina1, Peter P Swoboda1, Hui Xue4, John P Greenwood1, James C Moon3, Peter Kellman4, Sven Plein5.
Abstract
BACKGROUND: Non-invasive assessment of myocardial ischaemia is a cornerstone of the diagnosis of coronary artery disease. Measurement of myocardial blood flow (MBF) using positron emission tomography (PET) is the current reference standard for non-invasive quantification of myocardial ischaemia. Dynamic myocardial perfusion cardiovascular magnetic resonance (CMR) offers an alternative to PET and a recently developed method with automated inline perfusion mapping has shown good correlation of MBF values between CMR and PET. This study assessed the repeatability of myocardial perfusion mapping by CMR in healthy subjects.Entities:
Keywords: Cardiac magnetic resonance; Myocardial perfusion; Myocardial perfusion reserve
Mesh:
Substances:
Year: 2018 PMID: 29983119 PMCID: PMC6036695 DOI: 10.1186/s12968-018-0462-y
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Study Protocol. Group one consisted of 30 volunteers, Group two included 8 volunteers from Group one, and an additional 12 healthy volunteers
Fig. 2Rest and Stress MBF maps from visit 1 and visit 2 for the same subject. Values are displayed as ml/100 g/min
Intrastudy repeatability of global MBF measurements
| Test 1 | Test 2 ml/g/min | Difference in mean ml/g/min |
| RC | RC (%) | CV (%) | ICC | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rest | < 0.01 | ||||||||||
| Rest 1 - Rest 2 | 0.69 | ±0.13 | 0.65 | ±0.13 | −0.04 | ±0.09 | 0.04 | 0.19 | 28.5 | 10.9 | 0.73 |
| Rest 1 - Rest 3 | 0.69 | ±0.13 | 0.62 | ±0.12 | −0.07 | ±0.10 | 0.02 | 0.23 | 35.2 | 11.9 | 0.58 |
| Rest 2 - Rest 3 | 0.65 | ±0.13 | 0.62 | ±0.12 | −0.03 | ±0.07 | 0.24 | 0.15 | 23.8 | 7.93 | 0.80 |
| Stress | |||||||||||
| Stress 1- Stress 2 | 2.89 | ±0.56 | 2.83 | ±0.64 | −0.06 | ±0.42 | 0.41 | 0.82 | 28.5 | 10.6 | 0.76 |
p – from repeated measures ANOVA and level of significance using Bonferroni post-hoc analysis for rest data, Student’s T-test for stress values
RC repeatability coefficient, RC (%)repeatability coefficient as percentage of the mean, CV within subject coefficient of variation, ICC intraclass correlation coefficient
Fig. 3Global resting myocardial blood flow (MBF) on repeat throughout the same visit. A – uncorrected values, B – corrected values (mean and 95% confidence interval of the mean)
Fig. 4Intrastudy myocardial blood flow (MBF) repeatability (a) Rest 1–2 (b) Rest 2–3 (c) Stress 1–2
Global rest myocardial blood flow (MBF) corrected for heart rate (HR)
| Test 1 ml/g/min | Test 2 ml/g/min | Difference in mean ml/g/min |
| RC | RC (%) | CV (%) | ICC | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rest | < 0.01 | ||||||||||
| Rest 1 - Rest 2 | 0.69 | ±0.12 | 0.66 | ±0.10 | −0.03 | ±0.09 | 0.14 | 0.18 | 27.3 | 9.9 | 0.66 |
| Rest 1 - Rest 3 | 0.69 | ±0.12 | 0.61 | ±0.10 | −0.07 | ±0.07 | < 0.01 | 0.20 | 30.3 | 10.5 | 0.62 |
| Rest 2 - Rest 3 | 0.66 | ±0.10 | 0.61 | ±0.10 | −0.04 | ±0.06 | < 0.01 | 0.15 | 23.7 | 8.3 | 0.72 |
p – from repeated measures ANOVA and Bonferroni post-hoc analysis
RC repeatability coefficient, RC (%)repeatability coefficient as percentage of the mean, CV within subject coefficient of variation, ICC intraclass correlation coefficient
Interstudy repeatability of MBF measurements – by slice and coronary artery territory
| Test 1 | Test 2 | Difference in mean ml/g/min | p | RC | RC (%) | CV (%) | ICC | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rest | |||||||||||
| Global | 0.64 | ±0.13 | 0.64 | ±0.15 | 0.004 | ±0.10 | 0.8 | 0.20 | 31.5 | 11.3 | 0.74 |
| Basal | 0.66 | ±0.14 | 0.67 | ±0.16 | 0.015 | ±0.13 | 0.46 | 0.25 | 37.7 | 13.6 | 0.65 |
| Mid | 0.64 | ±0.14 | 0.64 | ±0.15 | −0.003 | ±0.10 | 0.87 | 0.20 | 31.0 | 11.2 | 0.76 |
| Apex | 0.60 | ±0.13 | 0.60 | ±0.15 | −0.003 | ±0.10 | 0.86 | 0.20 | 33.4 | 11.5 | 0.73 |
| | 0.13 | 0.089 | |||||||||
| LAD | 0.69 | ±0.16 | 0.68 | ±0.16 | −0.003 | ±0.11 | 0.86 | 0.22 | 32.2 | 11.7 | 0.75 |
| Cx | 0.60 | ±0.13 | 0.60 | ±0.14 | 0.005 | ±0.11 | 0.74 | 0.20 | 34.0 | 11.8 | 0.70 |
| RCA | 0.61 | ±0.12 | 0.62 | ±0.15 | 0.01 | ±0.11 | 0.59 | 0.22 | 35.6 | 12.6 | 0.66 |
| | 0.01* | 0.04* | |||||||||
| Stress | |||||||||||
| Global | 2.71 | ±0.61 | 2.55 | ±0.57 | −0.161 | ±0.43 | 0.12 | 0.87 | 33.1 | 12.2 | 0.72 |
| Basal | 3.01 | ±0.80 | 2.80 | ±0.74 | −0.209 | ±0.51 | 0.09 | 1.05 | 36.1 | 13.2 | 0.76 |
| Mid | 2.48 | ±0.55 | 2.39 | ±0.51 | −0.092 | ±0.44 | 0.38 | 0.86 | 35.4 | 13.4 | 0.66 |
| Apex | 2.62 | ±0.65 | 2.42 | ±0.56 | −0.201 | ±0.62 | 0.17 | 1.24 | 49.2 | 16.3 | 0.48 |
| | 0.05 | 0.07 | |||||||||
| LAD | 2.79 | ±0.61 | 2.62 | ±0.55 | −0.167 | ±0.39 | 0.08 | 0.82 | 30.3 | 10.8 | 0.75 |
| Cx | 2.69 | ±0.61 | 2.51 | ±0.66 | −0.180 | ±0.47 | 0.12 | 0.97 | 37.3 | 15.4 | 0.71 |
| RCA | 2.53 | ±0.61 | 2.44 | ±0.56 | −0.096 | ±0.47 | 0.39 | 0.92 | 37.0 | 13.6 | 0.68 |
| | 0.442 | 0.629 | |||||||||
| MPR | |||||||||||
| Global | 4.24 | ±0.69 | 3.73 | ±0.76 | −0.214 | ±0.76 | 0.25 | 1.46 | 36.4 | 13.3 | 0.46 |
| Basal | 4.53 | ±0.90 | 4.27 | ±1.00 | −0.262 | ±0.89 | 0.23 | 1.78 | 40.4 | 15.3 | 0.55 |
| Mid | 3.84 | ±0.70 | 3.73 | ±0.66 | −0.113 | ±0.83 | 0.57 | 1.60 | 42.4 | 15.5 | 0.26 |
| Apex | 4.42 | ±0.90 | 4.12 | ±0.76 | −0.293 | ±1.04 | 0.25 | 2.06 | 48.1 | 16.0 | 0.30 |
| | 0.047* | 0.130 | |||||||||
| LAD | 3.96 | ±0.58 | 3.83 | ±0.81 | −0.128 | ±0.71 | 0.45 | 1.35 | 35.3 | 13.1 | 0.50 |
| Cx | 4.47 | ±0.93 | 4.14 | ±0.93 | −0.325 | ±0.86 | 0.13 | 1.76 | 40.8 | 15.7 | 0.54 |
| RCA | 4.06 | ±0.76 | 3.91 | ±0.66 | −0.150 | ±0.89 | 0.49 | 1.72 | 43.3 | 15.7 | 0.23 |
| | 0.118 | 0.480 | |||||||||
RC repeatability coefficient, RC (%)repeatability coefficient as percentage of the mean, CV within subject coefficient of variation, ICC intraclass correlation coefficient
p – level of significance using Student’s T-test
*=significant at p < 0.05
Fig. 5Interstudy repeatability (a) Rest MBF (b) Stress (c) myocardial perfusion reserve (MPR)
Intra and inter-observer MBF reproducibility
| Intra-observer | Inter-observer | |||
|---|---|---|---|---|
| CV (%) | ICC | CV (%) | ICC | |
| Rest | ||||
| Global | 0.7 | 0.999 | 0.8 | 0.999 |
| Basal | 1.1 | 0.998 | 1.2 | 0.998 |
| Mid | 1.0 | 0.999 | 0.6 | 0.999 |
| Apical | 3.0 | 0.990 | 3.7 | 0.980 |
| LAD | 1.1 | 0.997 | 1.3 | 0.996 |
| Cx | 1.4 | 0.997 | 1.3 | 0.995 |
| RCA | 1.8 | 0.996 | 1.8 | 0.991 |
| Stress | ||||
| Global | 2.0 | 0.995 | 2.4 | 0.995 |
| Basal | 2.0 | 0.996 | 3.0 | 0.993 |
| Mid | 2.6 | 0.999 | 3.3 | 0.994 |
| Apical | 6.3 | 0.963 | 8.0 | 0.959 |
| LAD | 2.8 | 0.99 | 2.6 | 0.99 |
| Cx | 2.5 | 0.992 | 4.3 | 0.986 |
| RCA | 1.9 | 0.992 | 1.9 | 0.993 |
CV coefficient of variation, ICC intraclass correlation coefficient
Summary of literature on MBF repeatability
| Rest | Stress | MPR | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Author | Year | n | T test | r/ICC | RC | CV | T test | r/ICC | RC | CV | T test | r/ICC | RC | CV | |
|
| |||||||||||||||
| PET | Nitzsche [ | 1996 | 15 | 0.33 | 0.99 | 33 | 0.16 | 0.97 | 13 | ||||||
| Kaufmann [ | 1999 | 21 | ns | 18 | ns | 25 | ns | 33 | |||||||
| Wyss [ | 2003 | 11 | ns | 0.77 | 21 | 0.77 | 27 | ns | 0.74 | 35 | |||||
| Schindler [ | 2007 | 20 | 0.72 | 29 | 0.76 | 20 | |||||||||
| Manabe [ | 2009 | 15 | 0.31 | 22 | 0.81 | 27 | 0.53 | 37 | |||||||
| Kitkungvan [ | 2017 | 120 | 0.93 | 11 | 0.74 | 10 | |||||||||
| Ocneanu [ | 2017 | 12 | 21 | 15 | |||||||||||
| CMR | Keitha [ | 2017 | 10 | 53 | 13 | ||||||||||
| This study | 0.08 | 0.8 | 24 | 8 | 0.41 | 0.76 | 29 | 11 | |||||||
|
| |||||||||||||||
| PET | Nagamachi [ | 1996 | 30 | ns | 0.63 | 31 | ns | 0.69 | 18 | 20 | |||||
| Schindler [ | 2007 | 20 | 0.75 | 30 | 0.71 | 23 | |||||||||
| Sdringola [ | 2011 | 48 | 0.68 | 35 | ns | 0.53 | 34 | ns | 0.47 | 38 | |||||
| Johnson [ | 2015 | 50 | 0.46 | 41 | 0.13 | 34 | 0.29 | 34 | |||||||
| Kitkungvan [ | 2017 | 19 | 0.13 | 0.94 | 17 | 0.26 | 20 | ||||||||
| Kitkungvan [ | 2017 | 120 | 0.13 | 21 | 0.81 | 19 | |||||||||
| CMR | Jerosch-Herold [ | 2008 | 30 | 0.001 | 30 | 0.11 | 41 | ||||||||
| Larghata [ | 2013 | 11 | 0.2 | 45 | 20 | 0.61 | 73 | 40 | 0.11 | 69 | 35 | ||||
| Likhite [ | 2016 | 10 | 0.77 | 0.88 | |||||||||||
| Keitha [ | 2017 | 10 | 61 | 16 | |||||||||||
| This study | 0.8 | 0.74 | 32 | 11 | 0.12 | 0.72 | 33 | 12 | 0.25 | 0.44 | 36 | 13 | |||
ns not significant (p value not reported), r Pearson correlation coefficient, RC reproducibility coefficient (% of mean), CV coefficient of variation
aRepeatability data is given for single mid-ventricular slice, all other studies, data is for global myocardium, averaged from multiple slices. Where RC was not published, but sufficient data was provided, this has been calculated using 1.96*SD of difference. Similarly, all RC are given as % for ease of comparison